FindTrial
Sign In

A study for Cost-Effectiveness and Consequence in Carbapenem-resistant Enterobacteriaceae and Pseudomonas aeruginosa bloodstream infections

A study for Cost-Effectiveness and Consequence in Carbapenem-resistant Enterobacteriaceae and Pseudomonas aeruginosa bloodstream infections

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900025064
Enrollment
Unknown
Registered
2019-08-09
Start date
2019-08-01
Completion date
Unknown
Last updated
2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bloodstream infections

Interventions

Case series:Nil

Sponsors

the First Affiliated Hospital, College of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Blood culture positive for Enterobacteriaceae and Pseudomonas aeruginosa; 2. Clinical manifestations of infection; 3. Hospitalization and complete clinical data.

Exclusion criteria

Exclusion criteria: 1. Aged <16 years old; 2. KP isolated but with incomplete medical records; 3. treatment time after bloodstream infection <48 hours.

Design outcomes

Primary

MeasureTime frame
Cost-Effectiveness;—

Secondary

MeasureTime frame
outcome;—

Countries

China

Contacts

Public ContactYonghong Xiao

the First Affiliated Hospital, College of Medicine, Zhejiang University

xiaoyonghong@zju.edu.cn+86 15168338848

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026